Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes
复制标题
DOI:
10.1038/ng1732
复制
发表时间:
2006-03-01
期刊:
影响因子:
30.8
通讯作者:
Stefansson, K
中科院分区:
文献类型:
--
作者:
Grant, SFA;Thorleifsson, G;Stefansson, K
We have previously reported suggestive linkage of type 2 diabetes mellitus to chromosome 10q(1). We genotyped 228 microsatellite markers in Icelandic individuals with type 2 diabetes and controls throughout a 10.5-Mb interval on 10q. A microsatellite, DG10S478, within intron 3 of the transcription factor 7-like 2 gene (TCF7L2; formerly TCF4) was associated with type 2 diabetes (P = 2.1 X 10(-9)). This was replicated in a Danish cohort (P = 4.8 X 10(-3)) and in a US cohort (P = 3.3 X 10(-9)). Compared with non-carriers, heterozygous and homozygous carriers of the at-risk alleles (38% and 7% of the population, respectively) have relative risks of 1.45 and 2.41. This corresponds to a population attributable risk of 21%. The TCF7L2 gene product is a high mobility group box-containing transcription factor previously implicated in blood glucose homeostasis. It is thought to act through regulation of proglucagon gene expression in enteroendocrine cells via the Wnt signaling pathway(2).